141 related articles for article (PubMed ID: 11753238)
1. [Somatostatin receptors in non-endocrine tumours].
Casini Raggi C; Pinzani P; Gelmini S; Tricarico C; Orlando C; Calabrò A; Renzi D; Cianchi F; Valanzano R; Distante V; Cortesini C; Tonelli F; Cataliotti L; Cameron Smith M; Messerini L; Bianchi S; Pazzagli M; Serio M; Maggi M
Minerva Endocrinol; 2001 Sep; 26(3):149-58. PubMed ID: 11753238
[TBL] [Abstract][Full Text] [Related]
2. [Somatostatin and somatostatin receptors in the prostate].
Sinisi AA; Bellastella A; Pasquali D
Minerva Endocrinol; 2001 Sep; 26(3):159-63. PubMed ID: 11753239
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction.
Sestini R; Orlando C; Peri A; Tricarico C; Pazzagli M; Serio M; Pagani A; Bussolati G; Granchi S; Maggi M
Clin Cancer Res; 1996 Oct; 2(10):1757-65. PubMed ID: 9816127
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
[TBL] [Abstract][Full Text] [Related]
5. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells.
Dalm VA; van Hagen PM; van Koetsveld PM; Achilefu S; Houtsmuller AB; Pols DH; van der Lely AJ; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E344-53. PubMed ID: 12684217
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype expression in human tumors.
Hofland LJ; Lamberts SW
Ann Oncol; 2001; 12 Suppl 2():S31-6. PubMed ID: 11762349
[TBL] [Abstract][Full Text] [Related]
7. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.
Ben-Shlomo A; Schmid H; Wawrowsky K; Pichurin O; Hubina E; Chesnokova V; Liu NA; Culler M; Melmed S
J Clin Endocrinol Metab; 2009 Nov; 94(11):4342-50. PubMed ID: 19820006
[TBL] [Abstract][Full Text] [Related]
8. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
[TBL] [Abstract][Full Text] [Related]
10. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors.
Prevost G; Veber N; Viollet C; Roubert V; Roubert P; Benard J; Eden P
Neuroendocrinology; 1996 Feb; 63(2):188-97. PubMed ID: 9053784
[TBL] [Abstract][Full Text] [Related]
12. Re: Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer.
Buscail L
J Natl Cancer Inst; 1998 Jun; 90(11):864-5. PubMed ID: 9625179
[No Abstract] [Full Text] [Related]
13. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
[TBL] [Abstract][Full Text] [Related]
14. Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology.
Pinzani P; Orlando C; Raggi CC; Distante V; Valanzano R; Tricarico C; Maggi M; Serio M; Pazzagli M
Regul Pept; 2001 Jun; 99(2-3):79-86. PubMed ID: 11384768
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
Saveanu A; Gunz G; Guillen S; Dufour H; Culler MD; Jaquet P
Neuroendocrinology; 2006; 83(3-4):258-63. PubMed ID: 17047391
[TBL] [Abstract][Full Text] [Related]
16. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
Xu Y; Song J; Berelowitz M; Bruno JF
Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
[TBL] [Abstract][Full Text] [Related]
17. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
Seifert JK; Görges R; Bockisch A; Junginger T
Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.
Waser B; Cescato R; Liu Q; Kao YJ; Körner M; Christ E; Schonbrunn A; Reubi JC
Am J Pathol; 2012 May; 180(5):1942-9. PubMed ID: 22538189
[TBL] [Abstract][Full Text] [Related]
19. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]